Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature

Intern Med. 2017;56(14):1831-1837. doi: 10.2169/internalmedicine.56.7595. Epub 2017 Jul 15.

Abstract

Dermatomyositis or polymyositis as a paraneoplastic syndrome of hepatocellular carcinoma (HCC) is an uncommon event. Few cases have been reported in the literature. We herein report the case of a 55-year-old man with chronic hepatitis B and alcoholism who presented with skin rash. Abdominal computed tomography revealed multiple hypervascular liver tumors consistent with HCC. He subsequently developed dysphagia with proximal limb weakness. Laboratory tests and electromyography demonstrated inflammatory myopathy. We therefore diagnosed the patient with HCC-induced dermatomyositis. Prednisolone and anti-viral therapy were administered; however, the patient died two months later due to the progression of the disease. We review the cases of HCC-induced dermatomyositis and polymyositis in the literature.

Keywords: dermatomyositis; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; paraneoplastic syndrome; polymyositis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / physiopathology
  • Dermatomyositis / diagnosis
  • Dermatomyositis / drug therapy*
  • Dermatomyositis / etiology*
  • Disease Progression
  • Hepatitis B virus
  • Hepatitis B, Chronic / complications*
  • Humans
  • Liver Neoplasms / complications*
  • Liver Neoplasms / physiopathology
  • Male
  • Middle Aged
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / etiology
  • Prednisolone / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Prednisolone